Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci
- PMID: 24166409
- PMCID: PMC4165335
- DOI: 10.1038/mp.2013.145
Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci
Abstract
We report a GWAS of alcohol dependence (AD) in European-American (EA) and African-American (AA) populations, with replication in independent samples of EAs, AAs and Germans. Our sample for discovery and replication was 16 087 subjects, the largest sample for AD GWAS to date. Numerous genome-wide significant (GWS) associations were identified, many novel. Most associations were population specific, but in several cases were GWS in EAs and AAs for different SNPs at the same locus,showing biological convergence across populations. We confirmed well-known risk loci mapped to alcohol-metabolizing enzyme genes, notably ADH1B (EAs: Arg48His, P=1.17 × 10(-31); AAs: Arg369Cys, P=6.33 × 10(-17)) and ADH1C in AAs (Thr151Thr, P=4.94 × 10(-10)), and identified novel risk loci mapping to the ADH gene cluster on chromosome 4 and extending centromerically beyond it to include GWS associations at LOC100507053 in AAs (P=2.63 × 10(-11)), PDLIM5 in EAs (P=2.01 × 10(-8)), and METAP in AAs (P=3.35 × 10(-8)). We also identified a novel GWS association (1.17 × 10(-10)) mapped to chromosome 2 at rs1437396, between MTIF2 and CCDC88A, across all of the EA and AA cohorts, with supportive gene expression evidence, and population-specific GWS for markers on chromosomes 5, 9 and 19. Several of the novel associations implicate direct involvement of, or interaction with, genes previously identified as schizophrenia risk loci. Confirmation of known AD risk loci supports the overall validity of the study; the novel loci are worthy of genetic and biological follow-up. The findings support a convergence of risk genes (but not necessarily risk alleles) between populations, and, to a lesser extent, between psychiatric traits.
Conflict of interest statement
Although unrelated to the current study, Dr Kranzler has been a consultant or advisory board member for Alkermes, Lilly, Lundbeck, Pfizer and Roche. He is also a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which is supported by Lilly, Lundbeck, AbbVie and Pfizer.
Figures
References
-
- Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR, et al. Genomewide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry. 2013 Aug 20; doi: 10.1038/mp.2013.99. advance online publication, (e-pub ahead of print) - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- RC2 DA028909/DA/NIDA NIH HHS/United States
- U01HG004438/HG/NHGRI NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- K05 AA017435/AA/NIAAA NIH HHS/United States
- P01 CA089392/CA/NCI NIH HHS/United States
- R01 DA12849/DA/NIDA NIH HHS/United States
- R01 DA018432/DA/NIDA NIH HHS/United States
- K24 AA013736/AA/NIAAA NIH HHS/United States
- U01 HG004422/HG/NHGRI NIH HHS/United States
- R01 DA013423/DA/NIDA NIH HHS/United States
- T32 GM007205/GM/NIGMS NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- R01 AA017535/AA/NIAAA NIH HHS/United States
- R01 DA12690/DA/NIDA NIH HHS/United States
- U10 AA008401/AA/NIAAA NIH HHS/United States
- R01 DA18432/DA/NIDA NIH HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- R01 DA012690/DA/NIDA NIH HHS/United States
- N01 HG065403/HG/NHGRI NIH HHS/United States
- R01 AA11330/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
